Ultrasound-Enhancing Agents Market Outlook 2031
El agentes potenciadores de ultrasonido pronóstico de mercado se deriva de hallazgos de diversas fuentes de investigación secundarias y primarias. Según estimaciones de Insight Partners, el mercado estaba valorado en 756,61 millones de dólares en 2023 y se espera que alcance los 2.511,52 millones de dólares en 2031; se estima que registrará una tasa compuesta anual del 16,2 % entre 2023 y 2031.
Agentes potenciadores de ultrasonido, también conocidos como ultrasonido Los agentes de contraste (UCA) se inyectan para mejorar la resolución de las imágenes de los órganos durante una ecografía. Estos agentes consisten en suspensiones de microburbujas llenas de gas más pequeñas que los glóbulos rojos y reflejan señales de ultrasonido a medida que fluyen a través de la microcirculación en los vasos sanguíneos. Se expulsan del cuerpo a través de la orina o las deposiciones, pocos minutos después de la inyección. Estos agentes no contienen colorantes y se consideran seguros ya que no presentan ningún riesgo conocido de nefrotoxicidad.
Factores que impulsan Crecimiento del mercado de agentes potenciadores de ultrasonido
Las imágenes por ultrasonido son actualmente el primer paso para estimar la gravedad de las enfermedades oncológicas y enfermedades cardiovasculares, allanando el camino para una evaluación y un diagnóstico precisos mediante una mayor investigación. Se utiliza ampliamente para obtener imágenes en tiempo real de partes del cuerpo para la detección de anomalías debido a la portabilidad, el bajo costo, la seguridad y las capacidades de diagnóstico del sistema. Además, el uso de agentes de contraste ha mejorado significativamente la sensibilidad y especificidad de la ecografía para detectar estadios más tempranos de enfermedades, abriendo así nuevas posibilidades para la investigación celular y molecular en este campo. La creciente prevalencia de enfermedades crónicas como el cáncer, las enfermedades renales y los trastornos hepáticos impulsa la demanda de diagnósticos tempranos para un mejor tratamiento. Sus diagnósticos requieren modalidades de imágenes avanzadas para la detección temprana y el seguimiento de la salud de los pacientes diagnosticados. Los agentes potenciadores de ultrasonido permiten una visualización mejorada de tumores, lesiones y crecimiento anormal de tejido. Según un artículo publicado en radiopaedia.org en septiembre de 2023, Sonazoid, un agente de contraste utilizado en ecografías, mejora el contraste del hígado en la fase posvascular, lo que puede ayudar a detectar tumores hepáticos, especialmente aquellos sin metástasis de células de Kupffer. Sonazoid también ayuda a diferenciar entre nódulos regenerativos y displásicos de carcinomas hepatocelulares de fase temprana en un hígado cirrótico. Por lo tanto, la creciente adopción de AUC en el diagnóstico por imágenes aumenta el tamaño del mercado de agentes que mejoran la ecografía.
Según un artículo publicado en octubre de 2021 por la Sociedad Internacional de Ultrasonido de Contraste (ICUS). , 57 estudios de investigación originales se centraron únicamente en pacientes pediátricos, incluidos 4518 niños que se sometieron a 4906 exámenes de ultrasonido con contraste intravenoso hasta agosto de 2021. Además, los protocolos integrales desarrollados para evaluar la seguridad clínica demostraron el perfil de seguridad altamente favorable de los AUC cuando se usan por vía intravenosa e intravesical. y a través de otros procedimientos intracavitarios.
Segmentación y alcance del informe:
El "Análisis del mercado global de agentes potenciadores de ultrasonido to 2031" es un estudio especializado y en profundidad que se centra en la dinámica del mercado global para ayudar a identificar los factores impulsores clave, las tendencias futuras y las oportunidades lucrativas que, a su vez, ayudarían a identificar los principales focos de ingresos. El informe tiene como objetivo proporcionar una descripción general del mercado con una segmentación detallada del mercado por tipo, aplicación y usuario final. El alcance geográfico del informe de mercado de agentes potenciadores de ultrasonido implica América del Norte (EE. UU., Canadá y México), Europa (España, Reino Unido, Alemania, Francia, Italia y Resto de Europa), Asia Pacífico (Corea del Sur, China, India, Japón, Australia y Resto de Asia Pacífico), Medio Oriente y Asia. África (Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos y resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y resto de Centro y Suramérica).
Análisis segmentario:
El mercado de agentes potenciadores de ultrasonido, por tipo, se divide en la primera generación y segunda generación. El segmento de segunda generación tuvo una mayor participación de mercado en 2023. Se proyecta que registre una CAGR más alta de 2023 a 2031.
El mercado, por aplicación, se segmenta en; imágenes abdominales, imágenes cardiovasculares, imágenes del tracto urinario y otras. El segmento de imágenes abdominales representó la mayor cuota de mercado de agentes de mejora de ultrasonido en 2023. Se prevé que el segmento de imágenes cardiovasculares registre la CAGR más alta de 2023 a 2031.
Según el usuario final, el mercado se segmenta en hospitales, centros de diagnóstico e imágenes, y otros. El segmento de hospitales tuvo la mayor participación del mercado en 2023. Además, se espera que el segmento de centros de diagnóstico e imágenes registre la CAGR más alta de 2023 a 2031.
Perspectivas regionales:
América del Norte tuvo la mayor cuota de mercado de agentes de mejora de ultrasonidos en 2023. Estados Unidos dominó el mercado en esta región, en términos de participación, seguido de Canadá. El crecimiento del mercado en EE.UU. se atribuye a factores como la presencia de actores importantes, incluidos Lantheus Holdings Inc. y GE Healthcare. Estas empresas se centran cada vez más en empresas conjuntas y colaboraciones de investigación. Por ejemplo, GE Healthcare se centra en ampliar su cartera de productos lanzando productos innovadores y estableciendo asociaciones estratégicas con competidores. Además, un aumento en el número de procedimientos de ultrasonido debido a políticas de reembolso favorables respalda el crecimiento del mercado de agentes que mejoran el ultrasonido en los EE. UU.
< strong>Desarrollos de la industria y oportunidades futuras:
Según los comunicados de prensa de la compañía, algunas iniciativas tomadas por actores clave que operan en el mundo ;El mercado de agentes potenciadores de ultrasonido se enumeran a continuación:
- •En marzo de 2024, Samsung Medison y Bracco Imaging respaldaron un Acuerdo de Memorando de Entendimiento (MoU) para desarrollar una nueva área de dispositivos de diagnóstico por ultrasonido y agentes de contraste en el Congreso Europeo de Radiología (ECR) 2024, celebrado entre el 28 de febrero y el 3 de marzo en Viena, Austria. Dos empresas están considerando colaborar para desarrollar protocolos de diagnóstico por imágenes de alta frecuencia y súper resolución. La colaboración también incluiría actividades de marketing, atención de los proveedores de atención médica. educación y exploración de tecnologías de administración de medicamentos mejoradas con contraste dirigidas por ultrasonido con agentes farmacéuticos.•En abril de 2023, GE HealthCare lanzó Pixxoscan (Gadobutrol). Es un agente de contraste macrocíclico a base de gadolinio (GBCA) para imágenes por resonancia magnética no iónica. El producto se agregó a la cartera de medios de contraste para resonancia magnética de la compañía, que incluye Claiscan (ácido gadotérico macrocíclico) y Rapiscan (utilizado en resonancia magnética cardíaca de estrés para ayudar al diagnóstico de la enfermedad de las arterias coronarias)..
Panorama competitivo y empresas clave:
Lantheus Holdings Inc.; GE Atención sanitaria; Solstice Pharmaceuticals BV; FUJIFILM VisualSonics, Inc.; Bracco Diagnóstico Inc.; Bayer AG; y Vesselon se encuentran entre las empresas destacadas que se describen en el informe de mercado de agentes de mejora de ultrasonidos. Estas empresas se centran en nuevas tecnologías, avances de productos existentes y expansiones geográficas para satisfacer la creciente demanda de los consumidores en todo el mundo.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The ultrasound-enhancing agents market majorly consists of the players, including Lantheus Holdings Inc.; GE Healthcare; Solstice Pharmaceuticals B.V.; FUJIFILM VisualSonics, Inc.; Bracco Diagnostics Inc.; Bayer AG; and Vesselon.
The ultrasound-enhancing agents market is expected to be valued at US$ 2,511.52 million in 2031.
The ultrasound-enhancing agents market is bifurcated into the first generation and second generation. The second generation segment held a larger market share in 2023. It is projected to register a higher CAGR from 2023 to 2031.
Ultrasound-enhancing agents, also known as ultrasound contrast agents (UCA), are injected to enhance the resolution of images of the organs during an ultrasound scan. These agents consist of suspensions of gas-filled microbubbles smaller than red blood cells and reflect ultrasound signals as they flow through the microcirculation in the blood vessels. They are expelled from the body via urine or bowel movements, within minutes after injection. These agents do not contain any dyes and are considered safe as they pose no known risk of nephrotoxicity.
The ultrasound-enhancing agents informatics was valued at US$ 756.61 million in 2023.
Key factors driving the ultrasound-enhancing agents informatics growth are the increasing investments in the R&D of new drug molecules by pharmaceutical companies and the growing adoption of computational and information tools for ultrasound-enhancing agents and development.
The List of Companies - Ultrasound-Enhancing Agents Market
- Lantheus Holdings Inc.
- GE Healthcare
- Solstice Pharmaceuticals BV
- FUJIFILM VisualSonics, Inc.
- Bracco Diagnostics Inc.
- Bayer AG
- Vesselon
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2024
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
May 2024
Heart Transplant Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), End User (Hospitals, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Breath Analyzer Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Fuel Cell Technology, Semiconductor Sensor, Infrared Spectroscopy, and Others), Application (Drug Abuse Detection, Alcohol Detection, and Medical Applications), End User (Law Enforcement Agencies, Hospitals & Diagnostic Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Osteoarthritis Therapy Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (TENS, Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others), Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals and Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography
May 2024
Surgical Navigation Systems Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Optical Navigation System, Electromagnetic Navigation System, Hybrid Navigation System, Fluoroscopy Navigation System, CT-Based Navigation System, and Others), Application (Orthopedic, ENT, Neurology, Dental, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography
May 2024
Teleradiology Services Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Deployment Type (Cloud-based, Web-based), Modality (MRI, CT-Scan, X-ray, Ultrasound, Others), Application (Musculoskeletal System, Gastroentrology, Cardiology, Oncology, Neurology, Others), End User (Hospitals and Clinics, Diagnostic and Imaging Centers, Others), and Geography
May 2024
Pedicle Screws Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Polyaxial Pedicle Screw Systems, Monoaxial Pedicle Screw Systems, and Other Pedicle Screw Systems), Application (Fracture, Spinal Tumor, Scoliosis, Failed Fusion, and Spondylitis), Surgery Type (Open Surgery and Minimally Invasive Surgery), End User (Hospitals, Ambulatory Surgical Centers, and Other End User), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2024
Bovine Diagnostics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users) and Geography
Get Free Sample For